102 results
Page 4 of 6
F-1
f2lw2477w21m5 q9
3 Jun 19
Registration statement (foreign)
4:33pm
F-1
EX-10.1
5vtgw05g
3 Jun 19
Registration statement (foreign)
4:33pm
F-1
EX-1.1
hmt29fajuo8698afefi
3 Jun 19
Registration statement (foreign)
4:33pm
6-K
EX-99.3
kg4hw7d9n19dzf9dm
3 Jun 19
Current report (foreign)
7:00am
6-K
EX-99.1
7sy0q
3 Jun 19
Current report (foreign)
7:00am
6-K
EX-99.1
j8jb8 u0m2e29u
28 May 19
Current report (foreign)
7:23am
DRS
mldnt5
3 May 19
Draft registration statement
12:00am
20-F/A
EX-4.12
q9xipk fhlm
26 Apr 19
Annual report (foreign) (amended)
4:54pm
S-8
EX-5.1
i6mr84yjlnfepm lhkk
22 Mar 19
Registration of securities for employees
8:33am
20-F
EX-2.1
iup8e 8sggo81
22 Mar 19
Annual report (foreign)
8:02am
20-F
EX-1.1
cw3m5xdok
22 Mar 19
Annual report (foreign)
8:02am
20-F
4xpx lpl5cpo6
22 Mar 19
Annual report (foreign)
8:02am
20-F
EX-4.12
1l105009p4gbha5i63
22 Mar 19
Annual report (foreign)
8:02am
6-K
EX-99.1
bowpd bqox
21 Mar 19
Orchard Therapeutics Reports 2018 Financial Results and Reviews Recent Business Highlights
7:04am
6-K
EX-99.1
8ddgk0z5ezqtx
19 Mar 19
Orchard Therapeutics Strengthens Global Manufacturing and Supply Chain Leadership with Appointment of Ran Zheng as Chief Technical Officer
9:39am
6-K
EX-99.1
uhfag54e2vl8z5 5pr
7 Dec 18
Orchard Therapeutics Appoints Industry Veteran Alicia Secor to its Board of Directors
7:45am
424B4
id8tzvpry17l
31 Oct 18
Prospectus supplement with pricing info
4:36pm
S-8
EX-5.1
wg8e8k5obojz hbt
30 Oct 18
Registration of securities for employees
9:48pm
F-1/A
EX-5.1
wqcy1w3
26 Oct 18
Registration statement (foreign) (amended)
10:08am
F-1/A
EX-4.1
4q3ajk xqfaep
23 Oct 18
Registration statement (foreign) (amended)
6:15am